Treating the Young Aesthetic Patient: Evidence-Based Recommendations

June 2017 | Volume 16 | Issue 6 | Supplement Individual Articles | 81 | Copyright © June 2017


Lauren Meshkov Bonati MDa and Sabrina Guillen Fabi MDb

aIcahn School of Medicine at Mount Sinai, New York, NY bCosmetic Laser Dermatology, San Diego, CA

volume was seen in 63 patients at 21.6 months post-HA injection and 2.5 years after calcium hydroxylapatite injection.24-25 Poly-L- Lactic acid stimulates long-term neocollagenesis beginning 3-6 months post treatment and lasting up to 2 years or more.

Energy Devices

Lasers Skin laxity in this age group may be treated with various fractionated and non-fractionated, ablative and nonablative laser types. Although ablative lasers are known to be most efficacious,26 laser choice depends on patient budget and tolerance of downtime. Microfocused Ultrasound Skin laxity on the face, neck, chest, and arms may be treated with microfocused ultrasound (MFU), which causes thermal coagulation and neocollagenesis. In a retrospective study of 45 patients, face and neck laxity improved after MFU treatment in 75% and 77.8% of subjects, respectively, at 90 and 180-day follow-up, as per subject reporting.27 Radiofrequency Monopolar radiofrequency (MRF) causes thermal damage via high-frequency electric current and stimulates neocollagenesis. It is FDA approved for body laxity, facial lines, and cellulite. Upper eyelid tightening and reduced hooding was seen in 88% and 86% of patients, respectively, in a study of 63 subjects who underwent MRF treatment.28

CONCLUSION

The aging process is chronologically predictable, with outward manifestations beginning in the late 20’s and progressing with each decade. Appropriate cosmetic counseling, preventions, and interventions for younger populations are justified based on standard physiologic aging and individual concerns.

DISCLOSURES

Sabrina Guillen Fabi is an Investigator, Consultant, and Advisor for Galderma, Valeant, Allergan, and Merz. Dr Fabi serves on the Speakers bureau for Galderma, Allergan, Merz, Lumenis, and Coolsculpting. Lauren Meshkov Bonati has no conflicts of interest to declare.

REFERENCES

  1. Hamilton HK, Arndt KA. When is “too early” too early to start cosmetic pro- cedures? JAMA Dermatol. 2013;149(11):1271. 
  2. El-Domyati M, Attia S, Saleh F, et al. Intrinsic aging vs. photoaging: a comparative histopathological, immunohistochemical, and ultrastructural study of skin. Exp Dermatol. 2002;11(5):398-405. 
  3. Ditre CM, Grif n TD, Murphy GF, et al. Effects of alpha-hydroxy acids on photo aged skin: a pilot clinical, histologic, and ultrastructural study. J Am Acad Dermatol. 1996;34(2 Pt 1):187-95. 
  4. Grif ths CE, Russman AN, Majmudar G et al. Restoration of collagen formation in photodamaged human skin by tretinoin (retinoic acid). N Engl J Med. 1993;329:530–5. 
  5. Luebberding S, Krueger N, Kerscher M. Mechanical properties of human skin in vivo: a comparative evaluation in 300 men and women. Skin Res Technol. 2014;20(2):127-135. 
  6. Vleggaar D, Fitzgerald R. Dermatological implications of skeletal aging: a focus on supraperiosteal volumization for perioral rejuvenation. J Drugs Der- matol. 2008;7(3):209-90.
  7. Kuwazuru O, Miyamoto K, Yoshikawa N, et al. Skin wrinkling morphology changes suddenly in the early 30s. Skin Res Technol. 2012;18:495-503.
  8. Kimball AB, Multi-Decade and Ethnicity Study. Presented at 23rd World Congress of Dermatology, Vancouver, Canada, June 2015.
  9. Fitzpatrick RE, Rostan EF. Double-blind, half-face study comparing topical vitamin C and vehicle for rejuvenation of photodamage. Dermatol Surg. 2002;28(3):231-6.
  10. Hussain M, Phelps R, Goldberg DJ. Clinical, histologic, and ultra-structural changes after use of human growth factor and cytokine skin cream for the treatment of skin rejuvenation. J Cosmet Laser Ther. 2008;10:104–109.
  11. Carruthers A, Bruce S, de Coninck A et al. Efficacy and safety of onabotu- linumtoxinA for the treatment of crow’s feet lines: a multicenter, randomized, controlled trial. Dermatol Surg. 2014;4011:1181-1190.
  12. Trindade de Almeida A, Carruthers J, Cox SE, et al. Patient satisfaction and safety with aesthetic onabotulinumtoxinA after at least 5 years: a retrospec- tive cross-sectional analysis of 4,402 glabellar treatments. Dermatol Surg. 2015;41:S19-S28.
  13. Binder WJ, Rivken A. Long-term effects of onabotulinumtoxinA on facial lines: a 19-year experience of identical twins. Dermatol Surg. 2015;41:S64-S66.
  14. Chang AL, Bitter PH Jr, Qu K, et al. Rejuvenation of gene expression pattern of aged human skin by broadband light treatment: a pilot study. J Invest Dermatol. 2013;133(2):394-402.
  15. Cohen JL, Ross EV. Combined fractional ablative and nonablative laser resurfacing treatment: a split-face comparative study. J Drugs Dermatol. 2013;12(2):175-8.
  16. Ingargiola MJ, Motakef S, Chung MT, et al. Cryolipolysis for fat reduction and body contouring: safety and efficacy of current treatment paradigms. Plast Recontr Surg. 2015;135(6):1581-90.
  17. Jewell ML, Baxter RA, Cox SE, et al. Randomized sham-controlled trial to evaluate the safety and effectiveness of a high-intensity focused ul- trasound device for noninvasive body sculpting. Plast Reconstr Surg. 2011;128(1):253contr
  18. Jones DH, Carruthers J, Joseph JH, et al. REFINE-1, a multicenter, random- ized, double-blind, placebo-controlled, phase 3 trial with ATX-101, an inject- able drug for sub mental fat reduction. Dermatol Surg. 2016;42(1):38-49.
  19. Kaminer MS, Coleman WP 3rd, Weiss RA, et al. Multicenter pivotal study of vacuum-assisted precise tissue release for the treatment of cellulite. Derma- tol Surg. 2015;41(3):336-7.
  20. Katz B. Quantitative and qualitative evaluation of the efficacy of a 1440 nm Nd:YAG laser with novel bi-directional optical ber in the treatment of cel- lulite as measured by 3-dimensional surface imaging. J Drugs Dermatol. 2013;12(11):1224-30.
  21. Fabi SG, Goldman MP. Comparative study of hydroquinone-free and hydro- quinone-based hyperpigmentation regimens in treating facial hyperpigmen- tation and photoaging. J Drugs Dermatol. 2013;12(3):S32-7.
  22. Mendelson BC, Hartley W, Scott M, et al. Age-related changes of the orbit and midcheek and the implications for facial rejuvenation. Aesthetic Plast Surg. 2007;31:419–423.
  23. Taub AF, Sarnoff D, Gold M, et al. Effect of multisyringe hyaluronic acid facial rejuvenation on perceived age. Dermatol Surg. 2010;36(3):322-8.
  24. Mashiko T, Mori H, Kato H, et al. Semipermanent volumization by an absorb- able filler: onlay injection technique to the bone. Plast Reconstr Surg Glob Open. 2013;1(1).
  25. Pavicic T. Complete biodegradable nature of calcium hydroxylapatite after injection for malar enhancement: an MRI study. Clin Cosmet Investig Der- matol. 2015;8:19-25.
  26. Park SH, Kim DW, Jeong T. Skin-tightening effect of fractional lasers: com- parison of non-ablative and ablative fractional lasers in animal models. J Plast Recontr Aesthet Surg. 2012;65(10):1305-11.
  27. Fabi SG, Goldman MP. Retrospective evaluation of micro-focused ultrasound for lifting and tightening the face and neck. Dermatol Surg. 2014;40(5):569-75.
  28. Biesman BS, Baker SS, Carruthers J, et al. Monopolar radiofrequency treat- ment of human eyelids: a prospective, multi center, efficacy trial. Lasers Surg Med. 2006;38(10):890-8.

AUTHOR CORRESPONDENCE

Lauren Meshkov Bonati MD E-mail:................................................... [email protected]
Close Menu